| ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma N Concin, X Matias-Guiu, I Vergote, D Cibula, MR Mirza, S Marnitz, ... International Journal of Gynecological Cancer 31 (1), 12-39, 2021 | 1825 | 2021 |
| Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors M Esteller, JM Silva, G Dominguez, F Bonilla, X Matias-Guiu, E Lerma, ... JNCI: Journal of the National Cancer Institute 92 (7), 564-569, 2000 | 1546 | 2000 |
| NF-kB in development and progression of human cancer X Dolcet, D Llobet, J Pallares, X Matias-Guiu Virchows archiv 446, 475-482, 2005 | 1464 | 2005 |
| Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer M Scaltriti, F Rojo, A Ocaña, J Anido, M Guzman, J Cortes, S Di Cosimo, ... Journal of the National Cancer Institute 99 (8), 628-638, 2007 | 1085 | 2007 |
| FIGO staging of endometrial cancer: 2023 JS Berek, X Matias‐Guiu, C Creutzberg, C Fotopoulou, D Gaffney, ... International Journal of Gynecology & Obstetrics 162 (2), 383-394, 2023 | 613 | 2023 |
| Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis S Moran, A Martínez-Cardús, S Sayols, E Musulén, C Balañá, ... The Lancet Oncology 17 (10), 1386-1395, 2016 | 484 | 2016 |
| Molecular pathology of endometrial hyperplasia and carcinoma X Matias-Guiu, L Catasus, E Bussaglia, H Lagarda, A Garcia, C Pons, ... Human pathology 32 (6), 569-577, 2001 | 433 | 2001 |
| hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis M Esteller, L Catasus, X Matias-Guiu, GL Mutter, J Prat, SB Baylin, ... The American journal of pathology 155 (5), 1767-1772, 1999 | 405 | 1999 |
| ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer RE Miller, A Leary, CL Scott, V Serra, CJ Lord, D Bowtell, DK Chang, ... Annals of Oncology 31 (12), 1606-1622, 2020 | 404 | 2020 |
| Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological Pathologists RA Soslow, C Tornos, KJ Park, A Malpica, X Matias-Guiu, E Oliva, ... International journal of gynecological pathology 38, S64-S74, 2019 | 333 | 2019 |
| Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups T Bosse, RA Nout, JN McAlpine, MK McConechy, H Britton, YR Hussein, ... The American journal of surgical pathology 42 (5), 561-568, 2018 | 333 | 2018 |
| Clinicopathological and molecular characterisation of ‘multiple‐classifier’endometrial carcinomas A León‐Castillo, E Gilvazquez, R Nout, VT Smit, JN McAlpine, ... The Journal of pathology 250 (3), 312-322, 2020 | 327 | 2020 |
| Abnormalities of the APC/β-catenin pathway in endometrial cancer G Moreno-Bueno, D Hardisson, C Sanchez, D Sarrio, R Cassia, ... Oncogene 21 (52), 7981-7990, 2002 | 321 | 2002 |
| K‐ras mutations in mucinous ovarian tumors A clinicopathologic and molecular study of 95 cases M Cuatrecasas, A Villanueva, X Matias‐Guiu, J Prat Cancer 79 (8), 1581-1586, 1997 | 314 | 1997 |
| Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy P Domingo, X Matias-Guiu, RM Pujol, E Francia, E Lagarda, MA Sambeat, ... Aids 13 (16), 2261-2267, 1999 | 286 | 1999 |
| Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma MÁ Castilla, G Moreno‐Bueno, L Romero‐Pérez, KV De Vijver, ... The Journal of pathology 223 (1), 72-80, 2011 | 280 | 2011 |
| Molecular pathology of endometrial carcinoma X Matias‐Guiu, J Prat Histopathology 62 (1), 111-123, 2013 | 275 | 2013 |
| High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations R Murali, B Davidson, O Fadare, JA Carlson, CP Crum, CB Gilks, JA Irving, ... International Journal of Gynecological Pathology 38, S40-S63, 2019 | 259 | 2019 |
| PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases E Bussaglia, E Del Rio, X Matias-Guiu, J Prat Human pathology 31 (3), 312-317, 2000 | 235 | 2000 |
| PTEN promoter methylation in sporadic thyroid carcinomas F Alvarez-Nuñez, E Bussaglia, D Mauricio, J Ybarra, M Vilar, E Lerma, ... Thyroid 16 (1), 17-23, 2006 | 229 | 2006 |
